Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial.

Xuewei Ding, Han Liang, Qiang Xue et al.|Journal of Clinical Oncology|2022

Cited by 14